(1)子宮頸癌に対する妊孕性温存手術としての腹式広汎および単純子宮頸部摘出術について : 適格条件,術式の有用性,妊娠分娩例の検討(<特集>第62回学術講演会 シンポジウム1 婦人科癌における妊孕性温存治療(手術および薬物療法))
スポンサーリンク
概要
- 論文の詳細を見る
In 1986, Dargent performed the first vaginal radical trachelectomy associated with laparoscopic pelvic lymphadenectomy and reported that this procedure is also appropriate from the perspective of long-term prognosis. Thereafter Smith et al. began performing abdominal radial trachelectomy (ART) to address the problem of incomplete resection of the cardinal ligament in the vaginal approach. We began performing ART in June 2005 after IRB approval. We apply parametrial resection level in abdominal radical hysterectomy performed in Japan to our ART. We thought that our ART should also be performed for cervical cancer larger than those for which patients undergo vaginal radical trachelectomy overseas. Therefore, we established our independent eligibility criteria. The subjects of the present study were cases until March 2010 and the following were examined: (1) validity of the eligibility criteria, (2) specific surgical complications, and (3) progress of cases of pregnancy and childbirth. The preoperative eligibility criteria included general requirements such as women with a strong desire to have children but without infertility that is difficult to treat, without cancer of histologic type with poor prognosis, without suspicion of extrauterine spread on imaging, and without serious complications. Our independent criteria of ART consisted of the following. Criterion (a) was women who had stage I b1 or less advanced squamous cell cancer (including very early stage II a) with a transverse diameter of less than 3cm and with a cancer-free space between the tumor and internal os of at least 1cm. Criterion (b) was women who had stage. I b1 or less advanced adenocarcinoma with a transverse diameter of less than 2cm and with mainly exophytic growth. If the transverse and longitudinal diameters were almost the upper limits of the eligibility criteria, neoadjuvant chemotherapy (NAC) was performed after thorough discussion with the patient. Our independent criteria of abdominal simple trachelectomy (AST) consisted of the following. These early cancer cases underwent AST which does not require resection of cardinal ligaments. Criterion (c) was women who had stage I a1 or less advanced squamous cell carcinoma and who were at high risk for positive resection margins that could not be followed up after conization alone, or who had recurrence during follow-ups after conization. Criterion (d) was women who were at an earlier stage than stage I b1 adenocarcinoma with invasion within 3mm (FIGO stage I a1). The intraoperative eligibility criteria were women who were without lymph node metastasis by frozen-section evaluation, and without a lesion at the resection margin in the extirpated cervical area and in the cervical canal 5mm from the resection margin. We attempted ART in 52 patients (among whom 8 were NAC cases) in the period ending in March 2010. There were 6 patients who were excluded due to intraoperative histological examination (among whom 5 had lymph node metastases and one had a positive resection margin in the cervix). ART was performed in the remaining 46 patients. Postoperative adjuvant therapy included systemic chemotherapy and whole pelvic external irradiation. Systemic chemotherapy was performed in 6 patients with vascular permeation and deep stromal invasion. Whole pelvic external irradiation was performed in 1 patient with a sentinel node micrometastasis which was not identified intraoperatively but found postoperatively. Ten patients underwent AST. None had a positive sentinel node or a positive resection margin in the cervix, and AST was completed successfully in all 10 cases. No AST case required postoperative adjuvant therapy. The mean postoperative follow-up period was 24 months (range: 1〜58 months), and presently there have not been any cases of relapse. This procedure caused 3 specific postoperative complications: infection mainly in the uterovaginal anastomotic site, postoperative cervical stenosis, and uterine amenorrhea. There were 13 cases (23%) with infection at the anastomotic site, but all recovered within a few days of readministration of antibiotics. Recently, there has been a decreasing trend in infection at the anastomotic site because of monofilament threads used in uterovaginal sutures, postoperative use of broad spectrum prophylactic antibiotics, and daily postoperative vaginal lavage and antibiotic vaginal tablet. There were 18 cases (32%) that developed postoperative cervical stenosis. The cervical canal was dilated under anesthesia to avoid future obstruction. Recently, the frequency of dilation has decreased due to sutures placed more loosely in cervical cerclage and placement of FD-1^[○!R]. There were 4 cases (7%) with uterine amenorrhea. Initially, the Kuestner uterine forceps were used intraoperatively for grasping the uterus, but sufficient pressure developed to cause "crush" marks on the uterine body. Since November 2009, we have been using 3 absorbable threads passed through the bilateral round ligaments and the uterine fundus for grasping and traction. Suture traction has been used on 7 cases to date, and uterine amenorrhea has not been observed. There has been one patient who became pregnant after ART and one patient after AST. The former patient had a missed abortion at 8 weeks of pregnancy. The latter patient had a Cesarean section at 28 weeks and 0 days of pregnancy because a varix near the uterovaginal anastomotic site became enlarged and began to hemorrhage. This patient gave birth to a girl weighing 1,038g, and the varix rapidly disappeared with uterine contraction. We expanded the indications for trachelectomy and established new eligibility criteria. We have performed trachelectomy in a total of 56 cases to date, and it was completed safely in all. Although specific postoperative complications have occurred, there have not been any cases of relapse. We think valid eligibility criteria have been established. A randomized study cannot be conducted for trachelectomy, and therefore, it is difficult to establish a high level of evidence. Trachelectomy is a clinically investigative therapy whose evidence has not been established at this time. To establish high-quality evidence, it will be necessary to consolidate, accumulate, and standardize measures such as for postoperative complications, surgical techniques, and management methods.
- 2010-10-01
著者
関連論文
- (1)子宮頸癌に対する妊孕性温存手術としての腹式広汎および単純子宮頸部摘出術について : 適格条件,術式の有用性,妊娠分娩例の検討(婦人科癌における妊孕性温存治療(手術および薬物療法),シンポジウム1,第62回日本産科婦人科学会学術講演会)
- P3-216 再発・増悪Mullerian carcinomaに対するリポソーマルドキソルビシンの単剤投与例の検討(Group126 卵巣腫瘍11,一般演題,第62回日本産科婦人科学会学術講演会)
- P1-248 卵管癌と卵巣癌が重複した非常に稀な一例(Group30 その他の良性・悪性腫瘍3,一般演題,第62回日本産科婦人科学会学術講演会)
- P3-251 純粋型卵巣扁平上皮癌の3例(Group129 卵巣腫瘍14,一般演題,第62回日本産科婦人科学会学術講演会)
- K3-10 胞状奇胎の遺伝子多型に基づくDNA診断と予後に関する検討(高得点演題10 腫瘍,高得点演題プログラム,第61回日本産科婦人科学会学術講演会)
- P2-21 子宮頸癌手術におけるセンチネルリンパ節同定の試み(Group36 子宮頸部悪性腫瘍6,一般演題,第61回日本産科婦人科学会学術講演会)
- P3-285 子宮頸管妊娠における子宮動脈塞栓術の有用性に関する検討(Group111 子宮外妊娠2,一般演題,第61回日本産科婦人科学会学術講演会)
- P3-9 子宮内頸腺過形成から頸部腺癌を発症した2症例(Group77 子宮頸部悪性腫瘍8,一般演題,第61回日本産科婦人科学会学術講演会)
- P2-25 傍大動脈リンパ節転移を有する子宮頸癌症例における左前斜角筋リンパ節生検術の検討(Group37 子宮頸部悪性腫瘍7,一般演題,第60回日本産科婦人科学会学術講演会)
- P1-199 パクリタキセル耐性ヒト卵巣がん腫瘍を用いたMetronomic chemotherapyの有用性 : 血管新生抑制効果とtumor dormancy効果の検討(Group23 卵巣腫瘍1,一般演題,第60回日本産科婦人科学会学術講演会)
- P2-7 子宮頸癌に対する妊孕性温存trachelectomy後の妊娠中に生じた稀有な合併症 : 吻合部周囲静脈瘤よりの出血が生じた1例(Group34 子宮頸部悪性腫瘍4,一般演題,第61回日本産科婦人科学会学術講演会)
- 4-23.パクリタキセル投与時のペミロラストカリウム追加投与による過敏症反応抑制効果に関する検討(第15群 卵巣腫瘍2)(一般演題)
- Extra-GIST (Gastrointestinal stromal tumor) の一症例(その他の良性・悪性腫瘍IV, 第57回日本産科婦人科学会学術講演会)
- 22-7.卵巣癌細胞に対するアクチン結合蛋白カルポニンh1の遺伝子導入効果に関する検討(第104群 卵巣腫瘍15)(一般演題)
- 22-6.アクチン結合蛋白カルポニンh1が腹膜中皮に与える卵巣癌浸潤抑制効果の検討(第104群 卵巣腫瘍15)(一般演題)
- 卵巣癌初回化学療法としてのCEP療法とTJ療法の有用性の比較(第105群 卵巣腫瘍13)
- In vivoで樹立したパクリタキセル耐性卵巣癌細胞株の薬剤抵抗性と細胞生物学的形質の変化に関する解析(第66群 卵巣腫瘍4)
- P-308 筋層浸潤の疑わしい子宮内膜癌に対する術中迅速病理診断による病理組織学的危険因子の評価の信頼に関する検討
- P-301 子宮内膜癌におけるビメンチンの発現とそのリン酸化に関与するSerine-Threonine kinaseの同定
- P-11 子宮頸癌におけるインテグリン制御分子Mortility Related Protein 1/CD9の発現変化に関する検討
- (1)子宮頸癌に対する妊孕性温存手術としての腹式広汎および単純子宮頸部摘出術について : 適格条件,術式の有用性,妊娠分娩例の検討(第62回学術講演会 シンポジウム1 婦人科癌における妊孕性温存治療(手術および薬物療法))
- 254 子宮体癌におけるMortility Related Protein 1/CD9の発現変化に関する検討
- 11 子宮頸癌における傍大動脈リンパ節転移に対する術中照射の有用性に関する検討
- P2-23-14 感受性再発卵巣癌に対するカルボプラチン+リポソーマルドキソルビシン併用療法の検討(Group122 悪性卵巣腫瘍・治療2,一般演題,第63回日本産科婦人科学会学術講演会)
- P2-23-13 再発・増悪Mullerian carcinomaに対するリポソーマルドキソルビシン単剤療法の検討(Group122 悪性卵巣腫瘍・治療2,一般演題,第63回日本産科婦人科学会学術講演会)
- P2-16-5 子宮体癌における筋層浸潤の術中評価 : 肉眼的評価と組織学的評価の相関程度について(Group102 子宮体部悪性腫瘍・診断・手術1,一般演題,第63回日本産科婦人科学会学術講演会)
- P2-13-21 タキサン治療後の再発子宮頸癌に対する塩酸イリノテカン+シスプラチン療法の後方視的検討(Group95 子宮頸部腫瘍・治療6,一般演題,第63回日本産科婦人科学会学術講演会)
- K-20 胞状奇胎の病理診断に関するTSSC免疫染色の有用性 : DNA多型による遺伝子診断との比較検討(高得点演題5 腫瘍,第63回日本産科婦人科学会学術講演会)
- 1)積極適用の立場に立って((1)子宮頸癌に対するRadical Trachelectomy,1)腫瘍,1.クリニカルディベート,生涯研修プログラム,第63回日本産科婦人科学会学術講演会)
- 広汎子宮頸部摘出術の合併症 (今月の臨床 子宮頸癌--予防と妊孕性温存のための治療戦略) -- (妊孕性温存のための治療戦略)
- 1)積極適用の立場に立って((1)子宮頸癌に対するRadical Trachelectomy,1)腫瘍,クリニカルディベート,第63回日本産科婦人科学会 第63回学術講演会生涯研修プログラム,研修コーナー)